BIORCHESTRA announces that BMD-001 reduces Amyloid-β and Tau in non-human primate animal model of Alzheimer’s Disease at the RNA Leaders USA Conference in Boston
Back to list BIORCHESTRA Announces that its Proprietary Compound, BMD-001, Reduces Amyloid-β and Tau Inflammatory Symptoms in Primate Models for Alzheimer's Disease at the RNA Leaders USA Conference Boston, MA,…